CliffBio
small molecule

GEMONIL

METHARBITAL

Loss of exclusivity—loss of exclusivity
CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameGEMONIL
Active ingredientMETHARBITAL
Strength100MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from AbbVie Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

GEMONIL patent cliff — loss of exclusivity — | CliffBio